Mario Germano Giuliani is Director & 10% Owner at Royalty Pharma plc (RPRX). They have made 6 open-market trades across 1 company since 2020, most recently 2023-12-28.
CIK 0001814882
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.4M since 2020, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 2,753,186 | $167.9M |
Shares reported on the most recent Form 4, priced at the 2023-12-29 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 60% |
| Avg Move | +0.6% | +1.1% | +1.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | SELL | 2023-12-27 | 2023-12-29 | $28.17 | $14.2M | +2.2% | +3.8% | +8.5% |
| RPRX | SELL | 2023-12-15 | 2023-12-19 | $28.01 | $573K | +1.6% | +0.8% | +8.0% |
| RPRX | SELL | 2022-09-20 | 2022-09-22 | $41.08 | $43.0M | +1.9% | +0.9% | -3.2% |
| RPRX | SELL | 2022-09-16 | 2022-09-20 | $41.59 | $32.2M | -2.0% | -0.3% | -3.5% |
| RPRX | SELL | 2022-09-14 | 2022-09-16 | $42.38 | $29.2M | -1.0% | +0.3% | -2.1% |
| RPRX | BUY | 2020-06-18 | 2020-06-22 | $28.00 | $1.4M | -13.7% | -18.7% | -23.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.